( SEVAMED 2001)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)

(Click Here for Abstract)

Back To Content Page

1149.      Hoerauf A.  Volkmann L.  Nissen-Paehle K.  Schmetz C.  Autenrieth I. Buttner DW.  Fleischer B.Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin.Tropical Medicine & International Health.  5(4):275-9, 2000 Apr.

 1150.      Taylor MJ.  Cross HF.  Bilo K. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. Journal of Experimental Medicine.  191(8):1429-36, 2000 Apr 17.

 1151.      Thanomsub BW.  Chansiri K.  Sarataphan N.  Phantana S. Differential diagnosis of human lymphatic filariasis using PCR-RFLP. Molecular & Cellular Probes.  14(1):41-6, 2000 Feb.

 1668. Esterre P.  Plichart C. Huin-Blondey MO. Nguyen L.  Role  of  streptococcal  infection in the acute pathology of lymphatic filariasis. Parasite.  7(2):91-4, 2000 Jun.

 1669. Fontes  G.  Rocha  EM.  Brito  AC.  Fireman  FA.  Antunes  CM.  The  microfilarial periodicity  of  Wuchereria  bancrofti  in  north-eastern  Brazil.  Annals  of Tropical Medicine & Parasitology.  94(4):373-9, 2000 Jun.

 1670. Hoffmann W.  Petit G.  Schulz-Key H.  Taylor D.  Bain O.  Le Goff L. Litomosoides sigmodontis in mice: reappraisal of an old model for filarial  research.  [ Review ] [35 refs] Parasitology Today.  16(9):387-9, 2000 Sep.

 1671. Norman RA. Chan MS. Srividya A. Pani SP. Ramaiah KD. Vanamail P.Michael E. Das PK.  Bundy DA. EPIFIL :  the  development  of  an  age-structured  model  for describing   the   transmission   dynamics   and   control   of   lymphatic   filariasis. Epidemiology & Infection.  124(3):529-41, 2000 Jun.

 1672. Plaisier AP. Stolk WA. van Oortmarssen GJ.  Habbema JD.Effectiveness of annual ivermectin  treatment  for  Wuchereria  bancrofti  infection.  [ Review ]  [ 19 refs ] Parasitology Today.  16(7):298-302, 2000 Jul.

 1673. Ramzy RM.  Helmy H.  el-Lethy AS.  Kandil AM.  Ahmed ES.  Weil GJ.  Faris R. Field evaluation of a rapid-format kit for the diagnosis of bancroftian filariasis in Egypt. Eastern Mediterranean Health Journal.  5(5):880-7, 2000 Sep.

2157.      Esterre P.  Plichart C.  Sechan Y.  Nguyen NL. The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort.  Tropical Medicine & International Health.  6(3):190-5, 2001 Mar.

2158.      Freedman DO.  Plier DA.  De Almeida AB.  De Oliveira AL.  Miranda J.  Braga C. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Tropical Medicine & International Health.  6(1):37-41, 2001 Jan.

2159.      Gyapong M.  Gyapong JO.  Owusu-Banahene G.  Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Annals of Tropical Medicine & Parasitology.  95(1):77-86, 2001 Jan.

2160.      Jain S.  Sodhani P.  Gupta S.  Sakhuja P.  Kumar N.  Cytomorphology of filariasis revisited. Expansion of the morphologic spectrum and coexistence with other lesions. Acta Cytologica.  45(2):186-91, 2001 Mar-Apr.

2594.      Jain S.  Sodhani P.  Gupta S.  Sakhuja P.  Kumar N. Cytomorphology of filariasis revisited. Expansion of the morphologic spectrum and coexistence with other lesions. Acta Cytologica.  45(2):186-91, 2001 Mar-Apr.

2595.      Mohanty MC.  Satapathy AK.  Sahoo PK.  Ravindran B.  Human bancroftian filariasis - a role for antibodies to parasite carbohydrates. Clinical & Experimental Immunology.  124(1):54-61, 2001 Apr.

2596.      Rathaur S.  Sharma S.  Singh RN.  Henkle K.  Selkirk ME. Antibody responses of Wuchereria bancrofti patients to recombinant Brugia pahangi superoxide dismutase. Indian Journal of Experimental Biology.  39(1):35-40, 2001 Jan.


(Click Here for Abstract)

Back To Content Page